Breaking News

Europe awaits verdict on Johnson & Johnson

This Tuesday, the European Medicines Agency (EMA) is due to give its opinion on the vaccine developed by the American laboratory.

This Tuesday, the European Medicines Agency (EMA) is due to give its opinion on the vaccine developed by the American laboratory.

(AFP) – Depending on what the European Medicines Agency (EMA) will say this Tuesday afternoon, Johnson & Johnson will or will not resume delivery of its anti-covid vaccine. For Luxembourg, this would result in being able to count on 2,400 more doses by the end of the month, several million bottles for the rest of the Member States. This is to say if the opinion of the health authority which authorized the marketing of the American serum on the last 11 is awaited.

The EMA’s analysis is also closely scrutinized by the United States (which has just extended vaccination to all its citizens) or even in India (which, from May 1, will apply the vaccination to all adults in the country. ).

However, the uncertainty on the viability of this single-dose serum remains intact, while the American health authorities recommended last Tuesday “a pause” in the use of Johnson & Johnson in order to investigate the appearance of serious cases of clots. blood in several people in the United States. However, the most likely hypothesis remains a confirmed user agreement, perhaps accompanied by “restrictions”.

The covid situation remains precarious in Europe, although some countries have loosened health restrictions somewhat this week. This is the case to varying degrees in Switzerland, Belgium, Slovenia, Slovakia, Monaco, Portugal and Denmark.

Portugal thus entered on Monday the third phase of a gradual deconfinement started a month ago, with the reopening of shopping centers, the interior of cafes and restaurants, theaters, high schools and universities.

In Slovakia, a four-month lockdown ended Monday, to the delight of the population who took to the streets en masse. In Greece, the mandatory seven-day quarantine is lifted for travelers resident in the EU, UK, US, Israel, Serbia and the United Arab Emirates, if they have received two doses vaccine or have a negative coronavirus test.


Tags

Related Articles

Back to top button
Close
Close